Navigation Links
Cellestis Responds to World Health Organization Guidance on Use of Blood Tests for Active Tuberculosis
Date:7/25/2011

MELBOURNE, Australia, July 25, 2011 /PRNewswire/ -- A new policy recommendation released on 20 July by the World Health Organization (WHO) warns against the use of serological (blood) tests to diagnose active tuberculosis (TB). Serological tests measure antibodies to TB in serum and are different to QuantiFERON, which measures responses of white blood cells to TB specific proteins.  

Active tuberculosis occurs when the TB organism has overcome the body's immune defences and proliferates to cause clinical symptoms. According to WHO, TB takes one life every 17 seconds globally.(1) People with active disease often shed live TB bacteria and infect others. A person who is infected with the bacteria that causes TB, but who shows no symptoms and is not sick with the disease, is said to have latent TB infection (LTBI).(2) People with LTBI are at risk of developing active TB, particularly if their immune system becomes depressed.(2)

QFT is intended as an aid to the diagnosis of TB infection, both active and latent, and does not discriminate between the two conditions. Cellestis Limited, manufacturer of QuantiFERON®-TB Gold (QFT), has become aware that some media reports have caused confusion around the WHO announcement. The press release from WHO clearly notes that it refers to serological (antibody-based) blood tests for active TB, and their comments do not apply to Interferon-Gamma Release Assays (IGRAs) for diagnosing latent TB. This has been confirmed by direct correspondence by WHO to Cellestis.

"QuantiFERON-TB was developed in response to the poor quality of previous tests such as those referred by WHO. We thoroughly agree with the comments of WHO regarding serological tests for active TB," said Dr Jim Rothel, Chief Scientific Officer of Cellestis. "It is imperative to recognize that TB is still one of the world's deadliest diseases. We are confident that QFT has the ability to help reduce the future healthcare burden of TB, and
'/>"/>

SOURCE Cellestis Limited
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Takeda Responds to U.S. Food and Drug Administration Update to Safety Review of ACTOS (pioglitazone HCl)
2. Valeant Pharmaceuticals Responds to Cephalon Boards Letter
3. NCPA Responds to Consumer Groups Request for CVS Caremark Divestiture
4. Mangrove Partners Responds to Erroneous CPEX Assertions
5. Boston Scientific Responds to DOJ Civil Lawsuit
6. CPF Responds to Positive News on First Drug for Treatment for Pulmonary Fibrosis
7. Marken Rapidly Responds to Global Supply Chain Security Measures
8. PhRMA CEO John Castellani Responds to Mid-Term Election, Stresses Importance of Innovation to Help Grow Economy
9. FRCs Jeanne Monahan Responds to Two New Deaths from RU-486
10. Takeda Responds to Announcement about Suspension of Rosiglitazone Marketing Authorization in Europe and Restrictions in the U.S.
11. Atrium Responds to Bard Suit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Mass. , May 17, 2013  Boston Scientific ... participate at the annual EuroPCR Scientific Program May 21-24 ... are pleased to present a particularly rich and diversified ... Keith Dawkins , M.D., global chief medical ... trials will be presented, including the NG PROMUS trial, ...
(Date:5/16/2013)... FRANCISCO , May 16, 2013  Nektar Therapeutics, (Nasdaq: ... Howard W. Robin , is scheduled to present ... New York at the Sheraton New York ... time. The presentation will be accessible via a ... Calendar section of the Nektar website: http://www.nektar.com . This ...
(Date:5/16/2013)... Calif. , May 16, 2013  Amgen (NASDAQ: ... Sciences Conference on Tuesday, May 21, 2013, at the Sheraton ... , beginning at 10:00 a.m. Eastern Daylight Time. ... president of Research and Development at Amgen, will present at ... from the Events Calendar on Amgen,s website, www.amgen.com , ...
Breaking Medicine Technology:Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
... AMD patients, LOUISVILLE, Ky., Sept. 29 ... for the treatment,of age-related macular degeneration (AMD) announced ... shown early positive safety,results in its Phase I ... the complement activation cascade that could otherwise lead ...
... Foundation to improve healthcare,system in the Democratic Republic ... The Clinton Global,Initiative recognized BD (Becton, Dickinson ... medical technology company, for its commitment to the,Dikembe ... and,healthcare worker safety at the Biamba Marie Mutombo ...
Cached Medicine Technology:Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4 2Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital 2Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital 3
(Date:5/19/2013)... have long recognized ginger as a great way to ... savory dishes; now, a study from researchers at Columbia ... may have properties that help asthma patients breathe more ... presented at the ATS 2013 International Conference. , Asthma ... tubes that carry air into and out of the ...
(Date:5/19/2013)... In partnership with the medical practice online ... launch of an SEO website for dentists. The purpose of ... Google. , http://www.e-dentists.com/ , A perk to the ... until they see results. Dentists can request the keywords they ... by JD Media Surge, LLC rank high for competitive keywords. ...
(Date:5/19/2013)... May 19, 2013 According to ... Analysis and Forecast (2013 – 2018): By Applications ... Industrial)); Technology (CCD, CMOS, Contact IS, Infrared, X-Ray) ... image sensor market was $8.00 billion in 2012 ... 2018, at an estimated CAGR of 3.84% from ...
(Date:5/19/2013)... York, New York (PRWEB) May 19, 2013 ... that a Case Management Conference was recently convened for ... a federal multidistrict litigation now underway in U.S. District ... posted on the Court’s website on May 14th, the ... It was also reported during the Conference that ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Vegas Hotel ... is proud to announce the launch it's all new ... the MGM Grand on 5/19/2013. Consumers traveling to Las ... special pricing available on VegasHotelEscapes.com's website. Travelers will be ... beat any competitors price. , Vegas Hotel Escapes specializes ...
Breaking Medicine News(10 mins):Health News:Ginger compounds may be effective in treating asthma symptoms 2Health News:Effective New Dental SEO Solution Launched by E-dentists.com in Partnership with JD Media Surge, LLC 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3
... access to health care and education hinder minorities ... services and often lead to delayed cancer diagnoses. ... geared toward African-Americans, researchers with the University of ... Centers for Healthy Hearts and Souls, a Pittsburgh-based ...
... for reconciling medications across the healthcare continuum and broaden ... ... SAN BRUNO, Calif., Oct. 29 First DataBank announced,today ... Base(TM), a computerized physician order entry,(CPOE)-ready drug database designed for ...
... Cardica, Inc.,(Nasdaq: CRDC ) today announced that it ... shares of its common stock for sale by,Cardica and ... a selling,stockholder in an underwritten public offering. Cardica will ... the selling stockholder. Cardica,expects to grant the underwriters a ...
... SDA Urge Proper, Effective In-School Hygiene and Cleaning ... Many news stories have,reported on cases of students ... methicillin-resistant staphylococcus aureus -- MRSA for,short. Now a ... the steps that communities can take to combat ...
... China, Oct. 29 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE:,WX), ... today that Dr. Ge Li, the company,s Chairman ... Entrepreneur Of The Year (EOY) China,2007 Award. This ... 10 other,elite entrepreneurs on October 26 in the ...
... treatment recommendations, , , MONDAY, Oct. 29 (HealthDay News) ... for pediatricians to spot and begin early treatment ... Academy of Pediatrics has released two new reports ... , "Pediatricians are the front line" in identifying ...
Cached Medicine News:Health News:Education program leads to lasting improvement of cancer knowledge in African-Americans 2Health News:HealthTek Software Solutions Licenses First DataBank's OrderView Med Knowledge Base(TM) to Streamline Medication Selection, Management and Reconciliation 2Health News:HealthTek Software Solutions Licenses First DataBank's OrderView Med Knowledge Base(TM) to Streamline Medication Selection, Management and Reconciliation 3Health News:HealthTek Software Solutions Licenses First DataBank's OrderView Med Knowledge Base(TM) to Streamline Medication Selection, Management and Reconciliation 4Health News:Cardica Announces Proposed Public Offering of Common Stock 2Health News:Cardica Announces Proposed Public Offering of Common Stock 3Health News:Cleaning Hands, Saving Lives: The Spread of Staph Can Be Stopped 2Health News:Cleaning Hands, Saving Lives: The Spread of Staph Can Be Stopped 3Health News:WuXi PharmaTech (NYSE: WX) CEO Honored with Ernst & Young Entrepreneur Of The Year China 2007 Award 2Health News:WuXi PharmaTech (NYSE: WX) CEO Honored with Ernst & Young Entrepreneur Of The Year China 2007 Award 3Health News:Pediatricians' Group Issues New Autism Guidelines 2Health News:Pediatricians' Group Issues New Autism Guidelines 3
Multipiece PMMA IOL - Sulcus Fixation....
Hydrophilic Acrylic Intraocular Lens (Refractive and Bifocal). Anterior Chamber Lens....
Raysoft Foldable Intraocular Lens....
HAPTIBAG Hydrophilic Acrylic Lens....
Medicine Products: